US FTC Finds Major Pharmacy Benefit Managers Inflated Drug Prices for $7.3 Billion Gain
From 2017 to 2022, the companies -- UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts -- marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue in excess of the acquisition costs of the drugs, the FTC said in its second report on the industry.
Arkansas state laws tried to tackle inflated drug costs & limited pharmacy. Now lawmakers are going after Pharmacy Benefit ...
Pharmacy benefit managers actually "play a vital role in holding" sometimes-inflated prices down, said UHG CEO Andrew Witty ...
Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are ...
Futurism on MSN4h
Insurance Company Where CEO Was Assassinated Jacking Up Cost of Cancer Drugs by "Thousands of Percent," Government FindsUnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
A new research report from Colliers finds that the role of retail pharmacies has changed over time, moving far beyond roles ...
An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.
Atlanta News First on MSN1d
Cobb County files lawsuit against insulin manufacturers, pharmacy benefit managers for alleged price fixingCobb County has filed a lawsuit accusing several major insulin manufacturers and pharmacy benefit managers (PBMs) of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback